240 related articles for article (PubMed ID: 32762012)
1. Quality of life and patient satisfaction after implant-based breast reconstruction with or without acellular dermal matrix: randomized clinical trial.
Lohmander F; Lagergren J; Johansson H; Roy PG; Frisell J; Brandberg Y
BJS Open; 2020 Oct; 4(5):811-820. PubMed ID: 32762012
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial.
Negenborn VL; Young-Afat DA; Dikmans REG; Smit JM; Winters HAH; Don Griot JPW; Twisk JWR; Ruhé PQ; Mureau MAM; Lapid O; Moerman E; van Turnhout AAWM; Ritt MJPF; Bouman MB; Mullender MG
Lancet Oncol; 2018 Sep; 19(9):1205-1214. PubMed ID: 30104147
[TBL] [Abstract][Full Text] [Related]
3. Effect of Immediate Implant-Based Breast Reconstruction After Mastectomy With and Without Acellular Dermal Matrix Among Women With Breast Cancer: A Randomized Clinical Trial.
Lohmander F; Lagergren J; Johansson H; Roy PG; Brandberg Y; Frisell J
JAMA Netw Open; 2021 Oct; 4(10):e2127806. PubMed ID: 34596671
[TBL] [Abstract][Full Text] [Related]
4. Two-stage implant-based breast reconstruction compared with immediate one-stage implant-based breast reconstruction augmented with an acellular dermal matrix: an open-label, phase 4, multicentre, randomised, controlled trial.
Dikmans RE; Negenborn VL; Bouman MB; Winters HA; Twisk JW; Ruhé PQ; Mureau MA; Smit JM; Tuinder S; Eltahir Y; Posch NA; van Steveninck-Barends JM; Meesters-Caberg MA; van der Hulst RR; Ritt MJ; Mullender MG
Lancet Oncol; 2017 Feb; 18(2):251-258. PubMed ID: 28012977
[TBL] [Abstract][Full Text] [Related]
5. Implant Based Breast Reconstruction With Acellular Dermal Matrix: Safety Data From an Open-label, Multicenter, Randomized, Controlled Trial in the Setting of Breast Cancer Treatment.
Lohmander F; Lagergren J; Roy PG; Johansson H; Brandberg Y; Eriksen C; Frisell J
Ann Surg; 2019 May; 269(5):836-841. PubMed ID: 30308615
[TBL] [Abstract][Full Text] [Related]
6. Short-term cost-effectiveness of one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage expander-implant reconstruction from a multicentre randomized clinical trial.
Negenborn VL; Smit JM; Dikmans REG; Winters HAH; Twisk JWR; Ruhé PQ; Mureau MAM; Tuinder S; Eltahir Y; Posch NAS; van Steveninck-Barends JM; van der Hulst RRWJ; Ritt MJPF; Bouman MB; Mullender MG
Br J Surg; 2019 Apr; 106(5):586-595. PubMed ID: 30835827
[TBL] [Abstract][Full Text] [Related]
7. Does the use of acellular dermal matrices (ADM) in women undergoing pre-pectoral implant-based breast reconstruction increase operative success versus non-use of ADM in the same setting? A systematic review protocol.
Cook H; Zargaran D; Glynou SP; Hamilton S; Mosahebi A
Syst Rev; 2024 Jun; 13(1):153. PubMed ID: 38849880
[TBL] [Abstract][Full Text] [Related]
8. The Multi Centre Canadian Acellular Dermal Matrix Trial (MCCAT): study protocol for a randomized controlled trial in implant-based breast reconstruction.
Zhong T; Temple-Oberle C; Hofer SO; Beber B; Semple J; Brown M; Macadam S; Lennox P; Panzarella T; McCarthy C; Baxter N;
Trials; 2013 Oct; 14():356. PubMed ID: 24165392
[TBL] [Abstract][Full Text] [Related]
9. BROWSE: A multicentre comparison of nine year outcomes in acellular dermal matrix based and complete submuscular implant-based immediate breast reconstruction-aesthetics, capsular contracture and patient reported outcomes.
Wilson RL; Kirwan CC; O'Donoghue JM; Linforth RA; Johnson RK; Harvey JR
Eur J Surg Oncol; 2022 Jan; 48(1):73-81. PubMed ID: 34836730
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes of immediate implant-based breast reconstruction with and without biological or synthetic mesh.
Sewart E; Turner NL; Conroy EJ; Cutress RI; Skillman J; Whisker L; Thrush S; Barnes N; Holcombe C; Potter S;
BJS Open; 2021 Jan; 5(1):. PubMed ID: 33609398
[TBL] [Abstract][Full Text] [Related]
11. Review: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomized Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
Ng TP; Loo BYK; Yong N; Chia CLK; Lohsiriwat V
Ann Surg Oncol; 2024 May; 31(5):3366-3376. PubMed ID: 38285304
[TBL] [Abstract][Full Text] [Related]
12. Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial.
Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C
Eur J Surg Oncol; 2016 May; 42(5):665-71. PubMed ID: 26947961
[TBL] [Abstract][Full Text] [Related]
13. A controlled cost and outcomes analysis of acellular dermal matrix and implant-based reconstruction.
Aliotta RE; Duraes EFR; Scomacao I; Morisada M; Orra S; Moreira A; Bernard S; Schwarz G; Djohan R
J Plast Reconstr Aesthet Surg; 2021 Jun; 74(6):1229-1238. PubMed ID: 33526361
[TBL] [Abstract][Full Text] [Related]
14. Direct-to-implant breast reconstruction: Higher complication rate vs cosmetic benefits.
Gschwantler-Kaulich D; Leser C; Salama M; Singer CF
Breast J; 2018 Nov; 24(6):957-964. PubMed ID: 30230119
[TBL] [Abstract][Full Text] [Related]
15. Single-stage immediate breast reconstruction with acellular dermal matrix: Experience gained and lessons learnt from patient reported outcome measures.
Apte A; Walsh M; Chandrasekharan S; Chakravorty A
Eur J Surg Oncol; 2016 Jan; 42(1):39-44. PubMed ID: 26651226
[TBL] [Abstract][Full Text] [Related]
16. Development of an evidence-based approach to the use of acellular dermal matrix in immediate expander-implant-based breast reconstruction.
Ganesh Kumar N; Berlin NL; Kim HM; Hamill JB; Kozlow JH; Wilkins EG
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):30-40. PubMed ID: 33172826
[TBL] [Abstract][Full Text] [Related]
17. Extended Submuscular Implant-Based Breast Reconstruction with Pectoralis-Serratus Sling and Acellular Dermal Matrix.
Kolker AR; Piccolo PP
Aesthet Surg J; 2017 Apr; 37(4):485-491. PubMed ID: 28364524
[No Abstract] [Full Text] [Related]
18. Passot-Type Immediate Breast Reconstruction Obviates the Use of Aceullular Dermal Matrix in Grades 2 and 3 Ptosis.
Rivet JJ; Day KM; Rau JF; Waldrop JL; Brzezienski MA
Ann Plast Surg; 2019 Jun; 82(6S Suppl 5):S394-S398. PubMed ID: 30694845
[TBL] [Abstract][Full Text] [Related]
19. Acellular Dermal Matrix in Immediate Expander/Implant Breast Reconstruction: A Multicenter Assessment of Risks and Benefits.
Sorkin M; Qi J; Kim HM; Hamill JB; Kozlow JH; Pusic AL; Wilkins EG
Plast Reconstr Surg; 2017 Dec; 140(6):1091-1100. PubMed ID: 28806288
[TBL] [Abstract][Full Text] [Related]
20. Early complications and implant loss in implant-based breast reconstruction with and without acellular dermal matrix (Tecnoss Protexa®): a comparative study.
Potter S; Chambers A; Govindajulu S; Sahu A; Warr R; Cawthorn S
Eur J Surg Oncol; 2015 Jan; 41(1):113-9. PubMed ID: 24011501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
